SEC Info - Orthofix Medical Inc. - ‘10-Q’ for 9/30/23

SEC Info℠

Home

Help

Please Sign In

Orthofix Medical Inc. – ‘10-Q’ for 9/30/23 – ‘EX-10.2’

On: Wednesday, 11/8/23, at 4:15pm ET · For: 9/30/23 · Accession #: 950170-23-61148 · File #: 0-19961

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/08/23  Orthofix Medical Inc.             10-Q        9/30/23   90:13M                                    Donnelley … Solutions/FA

Quarterly Report — Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   3.30M 
 2: EX-10.1     Material Contract                                   HTML     64K 
 3: EX-10.2     Material Contract                                   HTML     63K 
 4: EX-10.3     Material Contract                                   HTML    109K 
 5: EX-10.4     Material Contract                                   HTML    169K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     31K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     31K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     29K 
14: R1          Document and Entity Information                     HTML     78K 
15: R2          Condensed Consolidated Balance Sheets               HTML    121K 
16: R3          Condensed Consolidated Balance Sheets               HTML     38K 
                (Parenthetical)                                                  
17: R4          Condensed Consolidated Statements of Operations     HTML    118K 
                and Comprehensive Loss                                           
18: R5          Condensed Consolidated Statements of Changes in     HTML     91K 
                Shareholders' Equity                                             
19: R6          Condensed Consolidated Statements of Cash Flows     HTML    127K 
20: R7          Pay vs Performance Disclosure                       HTML     39K 
21: R8          Insider Trading Arrangements                        HTML     34K 
22: R9          Business and basis of presentation                  HTML     35K 
23: R10         Recently adopted accounting standards, recently     HTML     50K 
                issued accounting pronouncements                                 
24: R11         Merger and Acquisitions                             HTML    298K 
25: R12         Inventories                                         HTML     45K 
26: R13         Leases                                              HTML    106K 
27: R14         Long-term debt                                      HTML     82K 
28: R15         Fair value measurements and investments             HTML    231K 
29: R16         Commitments and Contingencies                       HTML     38K 
30: R17         Accumulated other comprehensive loss                HTML     61K 
31: R18         Revenue recognition and accounts receivable         HTML    173K 
32: R19         Business segment information                        HTML    245K 
33: R20         Acquisition-Related Amortization and Remeasurement  HTML     64K 
34: R21         Share-based compensation                            HTML    116K 
35: R22         Income taxes                                        HTML     35K 
36: R23         Earnings per share ("Eps")                          HTML     70K 
37: R24         Goodwill                                            HTML     92K 
38: R25         Subsequent Events                                   HTML     32K 
39: R26         Recently adopted accounting standards, recently     HTML     41K 
                issued accounting pronouncements (Policies)                      
40: R27         Merger and Acquisitions (Tables)                    HTML    293K 
41: R28         Inventories (Tables)                                HTML     46K 
42: R29         Leases (Tables)                                     HTML    107K 
43: R30         Long-term debt (Tables)                             HTML     65K 
44: R31         Fair value measurements and investments (Tables)    HTML    233K 
45: R32         Accumulated other comprehensive loss (Tables)       HTML     60K 
46: R33         Revenue recognition and accounts receivable         HTML    172K 
                (Tables)                                                         
47: R34         Business segment information (Tables)               HTML    241K 
48: R35         Acquisition-Related Amortization and Remeasurement  HTML     63K 
                (Tables)                                                         
49: R36         Share-based compensation (Tables)                   HTML    108K 
50: R37         Earnings per share ("Eps") (Tables)                 HTML     66K 
51: R38         Goodwill (Tables)                                   HTML     91K 
52: R39         Recently adopted accounting standards, recently     HTML     54K 
                issued accounting pronouncements - Additional                    
                Information (Detail)                                             
53: R40         Merger and acquisitions -Schedule of Estimated      HTML     39K 
                Fair Value of Consideration Associated with Merger               
                (Detail)                                                         
54: R41         Merger and acquisitions - Additional Information    HTML     72K 
                (Detail)                                                         
55: R42         Merger and acquisitions - Summary of Fair Values    HTML    108K 
                of Assets Acquired and Liabilities Assumed                       
                (Detail)                                                         
56: R43         Merger and acquisitions - Summary of Pro Forma      HTML     31K 
                Financial Information (Detail)                                   
57: R44         Merger and acquisitions - Summary of Integration    HTML     41K 
                Costs Incurred (Detail)                                          
58: R45         Merger and Acquisitions - Summary of Restructuring  HTML     47K 
                Costs (Detail)                                                   
59: R46         Inventories - Schedule of Inventories (Detail)      HTML     36K 
60: R47         Leases - Summary of Lease Portfolio (Detail)        HTML     54K 
61: R48         Leases - Summary of Supplemental Cash Flow          HTML     37K 
                Information Related to Leases (Detail)                           
62: R49         Long-Term Debt - Additional Information (Detail)    HTML    100K 
63: R50         Long-Term Debt - Summary of Borrowing Activities    HTML     51K 
                (Details)                                                        
64: R51         Fair Value Measurements and Investments - Schedule  HTML     55K 
                of Financial Assets and Liabilities Measured at                  
                Fair Value on Recurring Basis (Detail)                           
65: R52         Fair Value Measurements and Investments -           HTML     43K 
                Additional Information (Detail)                                  
66: R53         Fair Value Measurements and Investments - Schedule  HTML     36K 
                of Reconciliation of Investments in Equity                       
                Securities (Detail)                                              
67: R54         Fair Value Measurements and Investments - Schedule  HTML     43K 
                of Reconciliation For Contingent Consideration                   
                Measured At Fair Value Using Significant                         
                Unobservable Inputs (Level 3) (Detail)                           
68: R55         Fair Value Measurements and Investments - Schedule  HTML     52K 
                of Valuation Methodology and Unobservable Inputs                 
                for Level 3 Assets and Liabilities Measured at                   
                Fair Value (Detail)                                              
69: R56         Commitments and Contingencies - Additional          HTML     35K 
                Information (Detail)                                             
70: R57         Accumulated other comprehensive loss - Components   HTML     46K 
                of Changes in Accumulated Other Comprehensive Loss               
                (Detail)                                                         
71: R58         Revenue Recognition and Accounts Receivable -       HTML     44K 
                Schedule of Net Sales by Major Product Category by               
                Reporting Segment (Detail)                                       
72: R59         Revenue Recognition and Accounts Receivable -       HTML     35K 
                Schedule of Components of Net Sales (Detail)                     
73: R60         Revenue Recognition and Accounts Receivable -       HTML     39K 
                Schedule of Allowance for Expected Credit Losses                 
                (Detail)                                                         
74: R61         Business Segment Information - Additional           HTML     28K 
                Information (Detail)                                             
75: R62         Business Segment Information - Summary of EBIDTA    HTML     65K 
                by Reporting Segment (Detail)                                    
76: R63         Business Segment Information - Summary of Net       HTML     46K 
                Sales by Geographic Destination for Each Reporting               
                Segment (Detail)                                                 
77: R64         Acquisition-Related Amortization and Remeasurement  HTML     35K 
                - Components of Acquisition-Related Amortization                 
                and Remeasurement (Detail)                                       
78: R65         Share-based Compensation - Schedule of Components   HTML     49K 
                of Share-Based Compensation Expense (Detail)                     
79: R66         Share-based Compensation - Additional Information   HTML     44K 
                (Detail)                                                         
80: R67         Income Taxes - Additional Information (Detail)      HTML     28K 
81: R68         Earnings Per Share ("EPS") - Schedule of            HTML     33K 
                Reconciliation of Weighted Average Shares Used in                
                Diluted EPS (Detail)                                             
82: R69         Earnings Per Share ("EPS") - Additional             HTML     32K 
                Information (Detail)                                             
83: R70         Goodwill - Additional Information (Detail)          HTML     28K 
84: R71         Goodwill - Schedule of Net Carrying Value of        HTML     48K 
                Goodwill and Activity Recognized (Detail)                        
85: R72         Subsequent Events - Additional Information          HTML     51K 
                (Detail)                                                         
88: XML         IDEA XML File -- Filing Summary                      XML    163K 
86: XML         XBRL Instance -- ofix-20230930_htm                   XML   3.60M 
87: EXCEL       IDEA Workbook of Financial Report Info              XLSX    144K 
13: EX-101.CAL  XBRL Calculations -- ofix-20230930_cal               XML    196K 
 9: EX-101.DEF  XBRL Definitions -- ofix-20230930_def                XML    757K 
12: EX-101.LAB  XBRL Labels -- ofix-20230930_lab                     XML   1.41M 
10: EX-101.PRE  XBRL Presentations -- ofix-20230930_pre              XML   1.10M 
11: EX-101.SCH  XBRL Schema -- ofix-20230930                         XSD    223K 
89: JSON        XBRL Instance as JSON Data -- MetaLinks              554±   859K 
90: ZIP         XBRL Zipped Folder -- 0000950170-23-061148-xbrl      Zip    422K

‘EX-10.2’ — Material Contract

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

EX-10.2

ORTHOFIX MEDICAL INC.

AMENDED AND RESTATED 2012 LONG-TERM INCENTIVE PLAN

Stock Unit Grant Agreement

COVER SHEET

Orthofix Medical Inc., a Delaware corporation (the “Company”), hereby grants to the Award Recipient named below, on the Grant Date set forth below, the specified number of Stock Units relating to shares of the Company’s common stock, par value $0.10 per share (the “Stock”) under the Plan, subject to the vesting schedule and terms and conditions set forth below (the “Award”). Additional terms and conditions of the Stock Units are set forth on this cover sheet, in the attached Stock Unit Grant Agreement (together, the “Agreement”), and in the Company’s Amended and Restated 2012 Long-Term Incentive Plan (as amended from time to time, the “Plan”). Capitalized terms used and not otherwise defined herein shall have the meanings attributed thereto in the Plan.


Grant Date:	[________________]
Name of Award Recipient:	[________________]
Employee ID Number:	[________________]
Number of Shares of Stock Underlying Stock Units:	[________________]

You agree to all of the terms and conditions described in this Agreement and in the Plan, unless you deliver a notice in writing within thirty (30) days of receipt of this Agreement to the Company stating that you do not accept the terms and conditions described in this Agreement and in the Plan. You acknowledge that you have carefully reviewed the Plan and agree that the Plan will control in the event any provision of this Agreement should appear to be inconsistent.

Attachment
This is not a stock certificate or a negotiable instrument.

ORTHOFIX MEDICAL INC.

AMENDED AND RESTATED 2012 LONG-TERM INCENTIVE PLAN

Stock Unit Grant Agreement

Attachment

Grant of Stock Units.

(a)

Vesting. Subject to earlier termination in accordance with the Plan or this Agreement and the terms and conditions herein, Stock Units granted under this Agreement shall vest in full ninety (90) calendar days following the date that a successor Chief Executive Officer assumes office following the Award Recipient’s discontinuation of service as Interim Chief Executive Officer (the “Vesting Date”) provided that Award Recipient continues in Service and has not had a Separation from Service on such date; provided further, however, for the avoidance of doubt, that there shall be no proportionate or partial vesting in the period prior to the Vesting Date; provided further, that for the avoidance of doubt, following Award Recipient’s Separation from Service, no additional Stock Units shall vest.

(b)

Additional Documents. The Award Recipient agrees to execute such additional documents and complete and execute such forms as the Company may require for purposes of this Agreement.

(c)

Issuance of Stock. The shares of Stock underlying the Award Recipient’s vested Stock Units will be issued as soon as practicable following the earlier of (i) the date that the Stock Units vest pursuant to the vesting schedule, or (ii) the date of the Award Recipient’s termination of Service, but in no event later than March 15 of the calendar year that immediately follows the first of such events (the date or dates such shares of Stock are delivered, the “Settlement Date”). The issuance of shares of Stock under this grant shall be evidenced in such a manner as the Company, in its discretion, will deem appropriate, including, without limitation, book-entry registration or issuance of one or more stock certificates. On the Settlement Date, the Company shall also deliver to the Award Recipient the number of additional shares of Stock, the number of any other securities of the Company and the amount of any other property (in the case of cash dividends, assuming such dividends had been reinvested in shares of Stock as of the ex-dividend date thereof), in each case that the Company distributed per share of Stock to holders generally during the period commencing on the Grant Date and ending on the Settlement Date, multiplied by the number of shares of Stock that are being delivered to the Award Recipient under this paragraph, without interest, and less any tax withholding amount applicable to such distribution. To the extent that the Stock Units are forfeited prior to vesting, the right to receive such distributions shall also be forfeited.

(d)

Shareholder Rights. The Award Recipient has no rights as a shareholder with respect to the shares of Stock underlying the Stock Units unless and until the Stock relating to the Stock Units has been delivered. No adjustments are made for dividends, distributions, or other rights if the applicable record date occurs before the certificate is issued (or appropriate book entry is made), except as described above.

Incorporation of Plan. The Award Recipient acknowledges receipt of the Plan, a copy of which is annexed hereto, and represents that he is familiar with its terms and provisions and hereby accepts this grant of Stock Units subject to all of the terms and provisions of the Plan and all interpretations, amendments, rules and regulations which may, from time to time, be promulgated and adopted pursuant to the Plan. The Plan is incorporated herein by reference. In the event of any conflict or inconsistency between the Plan and this Agreement, the Plan shall govern and this Agreement shall be interpreted to minimize or eliminate any such conflict or inconsistency.

Restrictions on Transfer. To the extent not yet vested, the Stock Units may not be sold, transferred, assigned, transferred, pledged, hypothecated, or otherwise encumbered or disposed of, whether by operation of law or otherwise, nor may the Stock Units be made subject to execution, attachment, or similar process. If the Award Recipient attempts to do any of these things, he will immediately and automatically forfeit the Stock Units.

Termination of Service; Corporate Transaction.

(a)

Certain Terminations of Service. If, prior to vesting, the Award Recipient’s Service is terminated for any reason other than (i) death, (ii) Disability, or (iii) a circumstance providing for accelerated vesting pursuant Section 4(c) hereof, the Stock Units shall be forfeited by the Award Recipient and cancelled by the Company as of the date of the Award Recipient’s termination of Service, and the Award Recipient shall have no further right or interest therein unless the Committee in its sole discretion shall determine otherwise.

(b)

Termination of Service for Death or Disability. If the Award Recipient’s Service terminates by reason of death or Disability, the Stock Units shall automatically vest in full as of the date of the Award Recipient’s termination of Service.

(c)

Certain Additional Corporate Transaction Circumstances. In the event that this Award is assumed or continued, or substituted for new restricted stock units or another equity-based Award of a successor entity, or parent or subsidiary thereof (with appropriate adjustments as to the number of shares), in each case upon the occurrence of any Corporate Transaction (or in the case of an Award Recipient who is party to a Change in Control and Severance Agreement, upon the consummation of any Change in Control (as defined in the Change in Control and Severance Agreement)), and the employment of the Award Recipient with the Company or an Affiliate is terminated within 24 months following the occurrence of such Corporate Transaction (or in the case of an Award Recipient who is party to a Change in Control and Severance Agreement, upon the consummation of such Change in Control (as defined in the Change in Control and Severance Agreement)) by the employer without Cause or by the Award Recipient for Good Reason, the Stock Units shall be fully vested on the date of such termination of employment with the Company. In the event a Corporate Transaction occurs (or in the case of an Award Recipient who is party to a Change in Control and Severance Agreement, in the event that a Change in Control (as defined in the Change in Control and Severance Agreement) occurs) in which this Award is not being assumed, continued or substituted (as contemplated by the preceding sentence), the Award shall be treated in accordance with the default rules applicable under Section 17.3 of the Plan.

Effect of Section 6 of Change in Control and Severance Agreements. The Company and the Award Recipient agree that this Agreement and the Stock Units granted hereunder are not subject to Section 6 of the Change in Control and Severance Agreement, and the Stock Units granted hereunder do not constitute Time-Based Restricted Stock as defined in such Change in Control and Severance Agreement.

Withholding.

The Company shall have the right to require the Award Recipient to remit to the Company any and all amounts sufficient to satisfy any withholding or other taxes that may be due as a result of the issuance of shares of Stock subject to the Stock Units. At the time of the Settlement Date (or, in the event that tax withholding is required as of an earlier date, then such earlier date), the Award Recipient shall pay in cash to the Company any amount that the Company may reasonably determine to be necessary to satisfy such withholding or other tax obligation. The Company shall have the right, but not the obligation, to permit or require the Award Recipient to satisfy, in whole or in part, such obligation to remit withholding or other taxes, (a) by directing the Company to withhold shares of Stock that would otherwise become vested, or (b) by entering into a “same day sale” commitment with a broker-dealer that is a member of the Financial Industry Regulatory Authority (a “FINRA Dealer”) whereby Award Recipient irrevocably elects to sell a portion of the shares of Stock to be delivered in connection with the Stock Units to satisfy withholding obligations and whereby the FINRA Dealer irrevocably commits to forward the proceeds necessary to satisfy the withholding obligations directly to the Company or any Affiliate in each case pursuant to such rules as the Committee may establish from time to time. The Company, in its sole discretion, may also permit, the Award Recipient to satisfy, in whole or in part, such obligation to remit withholding or other taxes, by delivering to the Company shares of Stock already owned by the Award Recipient and not then subject to any repurchase, forfeiture, unfulfilled vesting, or similar requirements. The Company shall also have the right to deduct from all cash payments made pursuant to, or in connection with, the Stock Units, the federal, state, or local taxes required to be withheld with respect to such payments. The maximum number of shares of Stock that may be withheld to satisfy any federal, state, or local tax requirements may not exceed such number of shares of Stock having a Fair Market Value equal to the minimum statutory amount required by the Company to be withheld and paid to any such federal, state, or local taxing authority with respect to such vesting or payment; provided, however,

for so long as Accounting Standards Update 2016-09 or a similar rule remains in effect, the Committee has full discretion to choose, or to allow the Award Recipient to elect, to withhold a number of shares of Stock having an aggregate Fair Market Value that is greater than the applicable minimum required statutory withholding obligation (but such withholding may in no event be in excess of the maximum required statutory withholding obligation in such Award Recipient’s relevant tax jurisdiction).

No Employment or Other Rights. This Award does not confer upon the Award Recipient any right to be continued in the employment of, or otherwise provide Services to, the Company or any Subsidiary or other affiliate thereof, or interfere with or limit in any way the right of the Company or any Subsidiary or other affiliate thereof to terminate such Award Recipient’s employment or other service relationship at any time. For purposes of this Agreement only, the term “employment” shall include circumstances under which Award Recipient provides consulting or other Services to the Company or any of its Subsidiaries as an independent contractor, but such Award Recipient is not, nor shall be considered, an employee; provided, however, nothing in this Section 7 or this Agreement shall create an employment relationship between such person and the Company or its applicable Subsidiary, as the usages described in this Section are for convenience only.

Adjustment of and Changes in Shares of Stock. In the event of any merger, consolidation, recapitalization, reclassification, stock dividend, extraordinary dividend, or other event or change in corporate structure affecting the shares of Stock, the Committee shall make such adjustments, if any, as it deems appropriate in the number and class of shares subject to the Stock Units. The foregoing adjustments shall be determined by the Committee in its sole discretion.

Discretionary Nature of Plan. The Plan is discretionary in nature, and the Company may suspend, modify, amend or terminate the Plan in its sole discretion at any time, subject to the terms of the Plan and any applicable limitations imposed by law. This Stock Unit grant under the Plan is a one-time benefit and does not create any contractual or other right to receive additional Stock Units or other benefits in lieu of Stock Units in the future. Future grants, if any, will be at the sole discretion of the Committee, including, but not limited to, the timing of any grant, the number of Stock Units granted, and the vesting provisions.

10.

Section 409A. The grant of Stock Units under this Agreement is intended to comply with Code Section 409A to the extent subject thereto, and, accordingly, to the maximum extent permitted, this Agreement will be interpreted and administered to be in compliance with Code Section 409A. Notwithstanding anything to the contrary in the Plan or this Agreement, neither the Company, its Affiliates, the Board, nor the Committee will have any obligation to take any action to prevent the assessment of any excise tax or penalty on Award Recipient under Code Section 409A, and neither the Company, its Affiliates, the Board, nor the Committee will have any liability to Award Recipient for such tax or penalty. For purposes of this Agreement, a termination of Service occurs only upon an event that would be a Separation from Service within the meaning of Section 409A. If, at the time of Award Recipient’s Separation from Service, (1) Award Recipient is a “specified employee” within the meaning of Code Section 409A, and (2) the Company makes a good faith determination that an amount payable on account of Award Recipient’s Separation from Service constitutes deferred compensation (within the meaning of Code Section 409A), the payment of which is required to be delayed pursuant to the six (6)-month delay rule set forth in Code Section 409A to avoid taxes or penalties under Code Section 409A (the “Delay Period”), then the Company will not pay such amount on the otherwise scheduled payment date but will instead pay it in a lump sum on the first business day after the Delay Period (or upon Award Recipient’s death, if earlier), without interest. Each installment of Stock Units that vest under this Agreement (if there is more than one installment) will be considered one of a series of separate payments for purposes of Code Section 409A.

11.

Miscellaneous Provisions.

(a)

Applicable Law. The validity, construction, interpretation and effect of this instrument will be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to the conflicts of law provisions thereof.

(b)

Notice. Any notice required by the terms of this Agreement shall be delivered or made electronically, over the Internet or otherwise (with request for assurance of recipient in a manner typical with respect to communications of that type), or given in writing. Any notice given in writing shall be deemed effective upon

personal delivery or upon deposit with the United States Postal Service, by registered or certified mail, with postage and fees prepaid, and shall be addressed to the Company at its principal executive office and to the Award Recipient at the address that he or she has most recently provided to the Company. Any notice given electronically shall be deemed effective on the date of transmission.

(c)

Headings. The headings of sections and subsections are included solely for convenience of reference and shall not affect the meaning of the provisions of this Agreement.

(d)

Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed to be an original but all of which together will constitute one and the same instrument.

(e)

Amendments. The Board and the Committee shall have the power to alter or amend the terms of the grant of Stock Units as set forth herein from time to time, in any manner consistent with the provisions of the Plan, and any alteration or amendment of the terms of this grant of Stock Units by the Board or the Committee shall, upon adoption, become and be binding on all persons affected thereby without requirement for consent or other action with respect thereto by any such person. The Committee shall give notice to the Award Recipient of any such alteration or amendment as promptly as practicable after the adoption thereof. The foregoing shall not restrict the ability of the Award Recipient and the Board or the Committee by mutual written consent to alter or amend the terms of this grant of Stock Units in any manner which is consistent with the Plan.

(f)

Binding Effect. This Agreement shall be binding upon the heirs, executors, administrators and successors of the Award Recipient and the Company.

(g)

Entire Agreement. This Agreement and the Plan constitute the entire agreement between the Award Recipient and the Company regarding the grant of Stock Units and supersede all prior arrangements or understandings (whether oral or written and whether express or implied) with respect thereto.

12.

Definitions. For purposes of this Agreement, the following capitalized words shall have the meanings set forth below.

“Cause” shall mean (i) if the Award Recipient is party to a Change in Control and Severance Agreement that defines “Cause,” the definition of “Cause” contained in such Change in Control and Severance Agreement, and (ii) if the Award Recipient is not party to a Change in Control and Severance Agreement that defines “Cause,” the definition of “Cause” contained in the Plan.

“Change in Control and Severance Agreement” shall mean a written change in control and severance agreement between the Award Recipient and the Company.

“Good Reason” shall mean (i) if the Award Recipient is party to a Change in Control and Severance Agreement that defines “Good Reason,” the definition of “Good Reason” contained in such Change in Control and Severance Agreement, and (ii) if the Award Recipient is not party to a Change in Control and Severance Agreement that defines “Good Reason,” the Award Recipient voluntarily terminating his employment, following a Corporate Transaction, after the occurrence of any of the following circumstances (in each case, after notice by the Award Recipient to employer of the circumstance, and failure by the employer to cure and eliminate such circumstance within 15 calendar days of such notice): (x) a requirement that the Award Recipient work principally from a location that is more than fifty (50) miles from his principal place of employment immediately prior to such Corporate Transaction, or (y) a ten percent or greater reduction in Award Recipient’s Total Compensation from the amount of such Total Compensation immediately prior to such Corporate Transaction.

“Separation from Service” shall have the meaning given such term in Code Section 409A.

“Total Compensation” shall mean aggregate of base salary, target bonus opportunity, employee benefits (retirement plan, welfare plans, and fringe benefits), and grant date fair value of equity-based compensation, but excluding for the avoidance of doubt any reductions caused by the failure to achieve performance targets) taken as a whole.

(Remainder of page intentionally left blank)

Dates Referenced Herein and Documents Incorporated by Reference

This ‘10-Q’ Filing	Date	Other Filings

Filed on:	11/8/23	8-K
For Period end:	9/30/23
		List all Filings

4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/05/24  Orthofix Medical Inc.             10-K       12/31/23  120:20M                                    Donnelley … Solutions/FA
 1/12/24  Orthofix Medical Inc.             S-8         1/12/24    8:693K                                   Donnelley … Solutions/FA
 1/08/24  Orthofix Medical Inc.             S-8         1/08/24    8:692K                                   Donnelley … Solutions/FA
11/08/23  Orthofix Medical Inc.             S-8        11/08/23    4:237K                                   Donnelley … Solutions/FA

↑Top

Filing Submission 0000950170-23-061148 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)